R$ 3.14
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Oncoclínicas do Brasil Serviços Médicos S.A. provides medical services focused on clinical oncology and radiotherapy in Latin America. It offers services in the areas of chemotherapy, radiotherapy, hormone therapy, molecular target drugs, immunotherapy, bone marrow transplant, catheter heparinization, non-oncological infusions, laser therapy, myelogram - bone marrow biopsy, continuous care, and precision medicine. The company was...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is neutral on EV/EBITDA.
Target Price
The average target price of ONCO3.SA is 4.7 and suggests 56% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
